Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Inspiremd Inc (NSPR)

0.955   -0.075 (-7.28%) 02-25 11:39
Open: 0.995 Pre. Close: 1.03
High: 1.02 Low: 0.9223
Volume: 5,430,808 Market Cap: 106M
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.072 - 1.078 1.078 - 1.083
Low: 0.975 - 0.982 0.982 - 0.989
Close: 1.019 - 1.03 1.03 - 1.04

Technical analysis

as of: 2021-02-25 11:14:59 AM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.34     One year: 1.73
Support: Support1: 0.62    Support2: 0.52
Resistance: Resistance1: 1.15    Resistance2: 1.48
Pivot: 1.09
Moving Average: MA(5): 1.03     MA(20): 0.99
MA(100): 0.53     MA(250): 0.55
MACD: MACD(12,26): 0.10     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 38.03     %D(3): 44.19
RSI: RSI(14): 50.57
52-week: High: 1.48  Low: 0.28  Change(%): 5.5
Average Vol(K): 3-Month: 1794959  10-Days: 1746458

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NSPR has closed above bottom band by 29.3%. Bollinger Bands are 198% wider than normal. The large width of the bands suggest high volatility as compared to NSPR's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue.

Headline News

Wed, 24 Feb 2021
InspireMD (NSPR) Moves Back Above $1 Mark: Up 125% YTD – Own Snap - Own Snap

Wed, 24 Feb 2021
InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States - GlobeNewswire

Fri, 19 Feb 2021
Do Traders Think InspireMD Inc (NSPR) Can Turn Around Friday? - InvestorsObserver

Fri, 12 Feb 2021
Analyst Rating: Will InspireMD Inc (NSPR) Stock Outperform the Market? - InvestorsObserver

Thu, 11 Feb 2021
Trade Alert: Gary Roubin At InspireMD, Inc. (NYSEMKT:NSPR), Has Just Spent US$150k Buying 52% More Shares - Simply Wall St

Mon, 08 Feb 2021
Thinking about buying stock in InspireMD, iBio, Nokia, Novan, or T2 Biosystems? - PRNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 33
Shares Float (M) 32
% Held by Insiders 10.95
% Held by Institutions 10.24
Shares Short (K) 810
Shares Short P. Month (K) 207

Stock Financials

EPS -1.550
EPS Est This Year -0.610
EPS Est Next Year -0.360
Book Value (p.s.) 0.400
Profit Margin -275.39
Operating Margin -271.90
Return on Assets (ttm) -41.5
Return on Equity (ttm) -96.7
Qtrly Rev. Growth -76.9
Gross Profit (p.s.) 0.023
Sales Per Share 0.099
EBITDA (p.s.) -0.264
Qtrly Earnings Growth
Operating Cash Flow (M) -7
Levered Free Cash Flow (M) -4

Stock Valuations

PE Ratio -0.61
PEG Ratio
Price to Book value 2.35
Price to Sales 9.49
Price to Cash Flow -4.32

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.